Explore our premium product line, engineered to meet strict international standards for pharmaceuticals, cosmetics, and animal nutrition.
Ursodeoxycholic Acid (UDCA), chemically known as 3α,7β-dihydroxy-5β-cholan-24-oic acid, is a naturally occurring hydrophilic bile acid. Although present in small quantities in human bile, it has become one of the most widely scrutinized and synthesized therapeutic compounds in gastrointestinal and hepatological healthcare. UDCA plays an indispensable role in modifying the bile acid pool, reducing toxic hydrophobic bile acids, stabilizing hepatocyte cell membranes, and exercising distinct immunomodulatory effects. As pharmaceutical companies scale up production of systemic treatments for Primary Biliary Cholangitis (PBC), non-alcoholic steatohepatitis (NASH), and cholesterol gallstones, understanding the pricing structures and manufacturer qualifications of UDCA Bile Acid is vital for global B2B procurement managers.
This industry report acts as a whitepaper to help procurement executives evaluate top-tier UDCA bile acid suppliers, dissect the components that influence global pricelists, capitalize on the strategic manufacturing strength of China-based production hubs, and ensure complete regulatory alignment with international validation boards like the FDA, CEP, and EDQM.
A premier high-tech enterprise dedicated to botanical extracts and natural pharmaceutical ingredients.
Established in 2012, Chengdu Chenlv Herb Co., Ltd. (known widely as "Chenlv Herb") operates as a specialized manufacturer, developer, and exporter of high-purity natural compounds. We specialize in botanical extraction, natural chemical synthesis, and customized API contract manufacturing services. Our facilities support industries ranging from pharmaceuticals and health supplements to functional food and cosmetics worldwide.
Our commitment to quality, clinical efficacy, and supply chain transparency guides our operations. By integrating research, scale manufacturing, and regulatory compliance, we provide customized botanical and chemical solutions that meet global standards.
B2B procurement of Ursodeoxycholic Acid requires a deep understanding of pricing structures. UDCA prices are not static. They are determined by raw material sourcing, synthesis routes, regulatory compliance, and batch purification standards. Companies must understand these dynamics to budget effectively and optimize their supply chains.
| Purity Grade (HPLC) | Primary Applications | Standard Regulatory Audits | Estimated Price Range (per KG) | Lead Time & Packaging |
|---|---|---|---|---|
| ≥ 99.0% (Pharma Grade) | Prescription drugs for PBC, Gallstone dissolution therapies | GMP, FDA DMF, CEP, EDQM | Contact Sales for Custom Quotes | 2-4 Weeks, 25kg fiber drums |
| ≥ 98.0% (Dietary / Nutraceutical Grade) | Liver support supplements, multi-ingredient formulations | ISO9001, Halal, Kosher, FDA Facility Reg. | Volume-dependent pricing | 1-2 Weeks, 25kg drums |
| ≥ 95.0% (Cosmetic / Animal Nutrition Grade) | Topical skincare additives, aquaculture health feeds | ISO22000, Veterinary approval certificates | Entry-level tier pricing | Prompt shipping, customized packs |
Raw Material Sourcing: The synthesis of UDCA begins with cholic acid (CA) or chenodeoxycholic acid (CDCA), which are traditionally extracted from animal bile. The supply and price of high-quality animal-derived bile directly affect the starting cost of UDCA. In response to these market factors, modern manufacturers are adopting biocatalytic methods and enzymatic synthesis, which help stabilize costs over the long term.
Purification & Crystallization Costs: Reaching pharmaceutical-grade purity (typically exceeding 99% via HPLC, as per EP/USP monographs) requires multiple crystallization steps. Removing impurity profiles, such as lithocholic acid (LCA)—a hepatotoxic compound—is critical. Manufacturers that invest in high-performance liquid chromatography (HPLC) testing and advanced recrystallization systems command higher prices due to the reliable quality and safety of their products.
Compliance & Document Logistics: Active Pharmaceutical Ingredients (APIs) registered with DMFs (Drug Master Files), CEPs (Certificates of Suitability), or GMP clearances require extensive regulatory documentation and auditing. The cost of maintaining these certifications is built into the final API pricelist, offering buyers reliable regulatory security and helping them avoid import delays.
How Chenlv Herb ensures reliability, innovation, and value across our entire product portfolio.
For global pharmaceutical companies and dietary supplement brands, China is a critical supply hub for high-purity Ursodeoxycholic Acid APIs. The country's robust chemical manufacturing infrastructure, coupled with its advanced logistics systems, provides significant advantages for buyers worldwide.
1. Vertically Integrated Raw Material Supply Chain: Chinese manufacturers operate in regions with access to essential starting materials, including cholic acid inputs and biochemical enzymes. This vertical integration reduces logistics costs, minimizes raw material shortages, and helps protect buyers from sudden price increases.
2. Advanced Scale and Automation: Plants like Chenlv Herb use modern, automated chemical reactors and crystallizers. These automated processes reduce human error, maximize yield per batch, and lower operating costs, allowing us to pass savings on to our clients through competitive bulk pricing.
3. Advanced Industrial Hub Logistics: Our facility in Chengdu, Sichuan, benefits from major transportation networks. This includes direct access to cargo rail links connecting China to Europe, and proximity to major shipping ports. This infrastructure ensures reliable shipping, helping international buyers maintain lean inventory levels.
UDCA and natural botanical ingredients support a range of industries, including human medicine and veterinary science.
Selling Active Pharmaceutical Ingredients and dietary components globally requires strict adherence to regional regulatory frameworks. At Chenlv Herb, we manage the compliance process to simplify imports and registration for our customers.
US Market Access (FDA & DMF): For US buyers, we maintain updated FDA facility registrations and prepare Drug Master Files (DMF) for our key products. This documentation facilitates the integration of our ingredients into final pharmaceutical formulations undergoing FDA review.
European Standards (CEP & REACH): We structure our manufacturing data to align with EDQM requirements, aiming for Certificates of Suitability (CEP) that verify compliance with European Pharmacopoeia (Ph. Eur.) monographs. Additionally, we address REACH declarations to support chemical import compliance across the EU.
Cultural & Quality Certifications: Our ingredients carry recognized certifications, including ISO9001 for quality systems, ISO22000 for food safety management, Halal, and Kosher certifications. These standards verify clean manufacturing processes and support global market entry.
Chenlv Herb provides comprehensive contract manufacturing and formulation services tailored to your specific requirements.
Our commitment to international standards is backed by globally recognized certifications.
Stay informed with updates from our team, market developments, and biochemical trends.
Answers to common technical and commercial questions about UDCA sourcing, purification, and use.
A: UDCA is primarily used to treat cholestatic liver diseases, including Primary Biliary Cholangitis (PBC). It helps lower the concentration of toxic, hydrophobic bile acids in the liver, protects hepatocyte membranes, and supports healthy bile flow. It is also used to dissolve radiolucent cholesterol gallstones in patients who prefer to avoid surgery.
A: UDCA (Ursodeoxycholic Acid) is a hydrophilic bile acid. CDCA (Chenodeoxycholic Acid) is its epimer, which is more hydrophobic and can cause gastrointestinal side effects at high therapeutic doses. TUDCA (Tauroursodeoxycholic Acid) is the taurine conjugate of UDCA; it is highly water-soluble and is often used in metabolic and neurological research applications.
A: Pricing variations are generally driven by the purification level (HPLC assay percentage), the origin of the starting raw material (animal-derived vs. synthetic/enzymatic), and regulatory certifications. APIs manufactured under cGMP with active DMF registrations and CEP certifications command higher prices due to the extensive documentation and testing required for clinical use.
A: We operate a modern GMP-compliant facility equipped with advanced purification systems. Each batch of UDCA and other botanical APIs undergoes strict quality control, including HPLC testing for purity, GC testing for residual solvents, and ICP-MS testing for heavy metals. We provide comprehensive Certificates of Analysis (COA) and regulatory support files with every shipment.
A: Our standard packaging for bulk powder is 25kg double-lined polyethylene bags inside fiber drums. When stored in a cool, dry place away from light, our UDCA has a shelf life of 36 months, during which it maintains its physical and chemical specifications.
Browse our catalog of natural extracts and raw materials, manufactured to meet international quality standards.
01
02
03
04
05
06
07
